Head of Data Management beats his personal best in the 2006 London Marathon

Posted:
28
April 2006

Adam Walker, Head of Richmond's Data Management service completed the 2006 London Marathon in 4 hours and 24 minutes - his best time in 3 years.Richmond Pharmacology Ltd sponsored Adam £500 to complete the run and in total he has raised £3,000 for Bliss, the premature baby charity.Training for this year's run started in December 2005, although he did have his setbacks."In February I was admitted to hospital and was put on a drip for 2 days with a mystery illness this happened just 6 weeks before the marathon. Fortunately I made a rapid recovery and was able to resume training."Next year he aims to complete the course in under 4 hours!"By mile 20 I had a massive burst of energy and pushed on for the last 6 miles - sprinting to the finishing line!"The charity Bliss is dedicated to caring for premature babies: "This is the third consecutive year I have run to support Bliss and over the 3 years I have raised more than £10,000 for the charity. My daughter Amelie Grace was born 6 weeks prematurely and was in intensive care at the Sussex County Hospital, Brighton for 4 weeks. I am very grateful that Amelie was able to make a full recovery. I will continue to raise money for Bliss to help other families who find themselves in the same position"To find out more about Bliss visit: www.bliss.org.ukTo sponsor Adam, visit: www.justgiving.com/adamwalker_londonmarathon2006.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more